Kazumi Iwata

发表

Up-regulation of aldose reductase by the substrate, methylglyoxal.

C. Yabe-Nishimura, H. Seo, T. Nishinaka, 2003, Chemico-biological interactions.

NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth.

C. Yabe-Nishimura, T. Nishinaka, Kazumi Iwata, 2006, Free radical biology & medicine.

Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice

Masato Matsuki, Kazumi Iwata, Shinji Takai, 2005, Circulation.

NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis.

Xueqing Zhang, Misaki Matsumoto, C. Yabe-Nishimura, 2021, Journal of pharmacological sciences.

NOX1/NADPH oxidase in bone marrow-derived cells modulates intestinal barrier function.

Xueqing Zhang, Misaki Matsumoto, C. Yabe-Nishimura, 2019, Free radical biology & medicine.

The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease

Xueqing Zhang, Natalie J Torok, Misaki Matsumoto, 2018, Free radical biology & medicine.

NOX1/NADPH Oxidase Expressed in Colonic Macrophages Contributes to the Pathogenesis of Colonic Inflammation in Trinitrobenzene Sulfonic Acid–Induced Murine Colitis

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2017, The Journal of Pharmacology and Experimental Therapeutics.

NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.

Misaki Matsumoto, C. Yabe-Nishimura, K. Sharma, 2015, Free radical biology & medicine.

A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia.

C. Yabe-Nishimura, Kazumi Iwata, Akio Matsumoto, 2015, Journal of pharmacological sciences.

Deficiency of NOX1/Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form Oxidase Leads to Pulmonary Vascular Remodeling

Misaki Matsumoto, T. Yamashita, C. Yabe-Nishimura, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.

C. Yabe-Nishimura, K. Takeuchi, N. Yamanaka, 2012, American journal of physiology. Gastrointestinal and liver physiology.

NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis.

H. Matsubara, Misaki Matsumoto, S. Takai, 2012, Free radical biology & medicine.

NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation

Natalie J Torok, Misaki Matsumoto, C. Yabe-Nishimura, 2011, Hepatology.

Involvement of NOX1/NADPH Oxidase in Morphine-Induced Analgesia and Tolerance

Misaki Matsumoto, C. Yabe-Nishimura, T. Nakagawa, 2011, The Journal of Neuroscience.

NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models.

C. Yabe-Nishimura, Kazumi Iwata, Kanako Ikami, 2009, Journal of pharmacological sciences.

The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway.

C. Yabe-Nishimura, Kazumi Iwata, M. Çevik, 2008, Biochemical and biophysical research communications.

Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide‐producing enzyme

Noriaki Arakawa, C. Yabe-Nishimura, T. Nishinaka, 2007, The FEBS journal.

The activity of aldose reductase is elevated in diabetic mouse heart.

C. Yabe-Nishimura, T. Nishinaka, Kazumi Iwata, 2007, Journal of pharmacological sciences.

Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism.

C. Yabe-Nishimura, T. Nishinaka, Kazumi Iwata, 2006, Journal of pharmacological sciences.

Increased gene expression of glutathione peroxidase-3 in diabetic mouse heart.

C. Yabe-Nishimura, T. Nishinaka, Kazumi Iwata, 2006, Biological & pharmaceutical bulletin.

Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element.

C. Yabe-Nishimura, T. Nishinaka, Kazumi Iwata, 2007, Toxicology letters.

Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling.

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2012, Toxicology.

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2020, Archives of Toxicology.

Clioquinol increases the expression of interleukin‐8 by down‐regulating GATA‐2 and GATA‐3

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2018, Neurotoxicology.

NOX1/NADPH Oxidase Promotes Synaptic Facilitation Induced by Repeated D2 Receptor Stimulation: Involvement in Behavioral Repetition

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2021, The Journal of Neuroscience.

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

Misaki Matsumoto, C. Yabe-Nishimura, Kazumi Iwata, 2020, Archives of Toxicology.